Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion type Assertion NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_head.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion description "[Although the reduction of the diagnostic window with NAT screening on maxi-pools may be relatively low, it may help to improve the residual risk of blood donation, especially in asymptomatic HBV infection, where the HBsAg positive period may be very short and low levels of circulating surface antigen are present.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_provenance.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion evidence source_evidence_literature NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_provenance.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion SIO_000772 15572009 NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_provenance.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion wasDerivedFrom befree-20150227 NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_provenance.
- NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_assertion wasGeneratedBy ECO_0000203 NP673256.RAVAa2GH4He6LLS3LWPQtKNW5lrz3et1_vAAs8m1DLznA130_provenance.